Myasthenia gravis

Last updated: December 12, 2025

Myasthenia gravis

Watch later

Watch later

Anatomy clinical correlates: Foot
Anatomy clinical correlates: Hip, gluteal region and thigh
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Anatomy of the anterior and medial thigh
Anatomy of the foot
Anatomy of the hip joint
Anatomy of the knee joint
Anatomy of the leg
Joints of the ankle and foot
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Pediatric musculoskeletal disorders: Pathology review
Juvenile idiopathic arthritis: Clinical sciences
Approach to common musculoskeletal injuries (pediatrics): Clinical sciences
Osteoporosis
Slipped capital femoral epiphysis
Osteomyelitis
Septic arthritis
Developmental dysplasia of the hip: Clinical sciences
Septic arthritis: Clinical sciences
Legg-Calve-Perthes disease
Osgood-Schlatter disease (traction apophysitis)
Borrelia burgdorferi (Lyme disease)
Lyme disease: Clinical sciences
Spina bifida
Polymyalgia rheumatica
Vitiligo
Bullous pemphigoid
Carpal tunnel syndrome
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Approach to compressive mononeuropathies: Clinical sciences
Brachial plexus
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Axilla
Erb-Duchenne palsy
Klumpke paralysis
Folate (Vitamin B9) deficiency
Acetaminophen (Paracetamol)
Developmental dysplasia of the hip
Temporal arteritis: Clinical sciences
Myasthenia gravis
Reactive arthritis
Sarcoidosis
Lambert-Eaton myasthenic syndrome
Ehlers-Danlos syndrome
Sjogren syndrome
Atopic dermatitis
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Rheumatoid arthritis
Henoch-Schonlein purpura: Clinical sciences
Basal cell carcinoma: Clinical sciences
Benign skin lesions: Clinical sciences
Acne vulgaris
Compartment syndrome
Muscular dystrophies and mitochondrial myopathies: Pathology review
Non-biologic disease modifying anti-rheumatic drugs (DMARDs)
Rheumatoid arthritis: Clinical sciences
Ankylosing spondylitis
Psoriatic arthritis
Non-steroidal anti-inflammatory drugs
Epidermolysis bullosa: Year of the Zebra
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Dermatomyositis
Approach to common skin rashes: Clinical sciences
Acneiform skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Scleroderma: Pathology review
Sjogren syndrome: Pathology review
Collagen disorders: Pathology review
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Cocaine use disorder
Anatomy of the lungs and tracheobronchial tree
Antimalarials
Plasmodium species (Malaria)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sideroblastic anemia
Autoimmune hemolytic anemia
Iron deficiency anemia
Aplastic anemia
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Heparin-induced thrombocytopenia
Blood histology
Deep vein thrombosis
Deep vein thrombosis: Clinical sciences
Pulmonary embolism
Pulmonary embolism: Clinical sciences
Deep vein thrombosis and pulmonary embolism: Pathology review
Allergic rhinitis
Allergic rhinitis: Clinical sciences
Pneumonia
Goodpasture syndrome
Neonatal respiratory distress syndrome: Clinical sciences
Esophageal atresia and tracheoesophageal fistula: Year of the Zebra
Pneumothorax
Pneumothorax: Clinical sciences
Cystic fibrosis
Pulmonary hypertension
Upper respiratory tract infection
Upper respiratory tract infections: Clinical sciences
Acute respiratory distress syndrome
Reading a chest X-ray
Pleural effusion: Clinical sciences
Anatomy of the heart
Hirschsprung disease: Year of the Zebra
Sphincter of Oddi dysfunction: Year of the Zebra 2024
Esophageal cancer
Diverticulosis and diverticulitis
Cleft lip and palate
Treacher Collins syndrome
Bowel obstruction
Celiac disease
Tropical sprue
Lactose intolerance
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Multiple endocrine neoplasia
Irritable bowel syndrome
Portal hypertension
Nutcracker syndrome
Potter sequence
Multicystic dysplastic kidney
Horseshoe kidney
Kidney stones
Renal agenesis
Renal azotemia
Metabolic acidosis
Chronic kidney disease
Medullary sponge kidney
Renal cell carcinoma
Nephroblastoma (Wilms tumor)
von Hippel-Lindau disease
Anatomy of the female reproductive organs of the pelvis

Flashcards

Myasthenia gravis

0 of 12 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 5 complete

Start
A 40-year-old woman begins complaining of dyspnea while recovering in the post-anesthesia care unit. Earlier in the day, the patient underwent a laparoscopic cholecystectomy for treatment of symptomatic gallstones. Past medical history is unremarkable. Her temperature is 37.7°C (99.9°F), pulse is 93/min, respiratory rate is 24/min and blood pressure is 125/72 mmHg. Physical examination shows the patient in distress with shallow breaths, using accessory muscles. In addition, the patient is observed to have drooping of the eyelids and corners of the mouth bilaterally. Pupils are 3 cm bilaterally and reactive to light. An arterial blood gas measurement reveals the following findings:  

 Laboratory Value  Result  Reference Range 
 pH  7.31  7.35-7.45 
 PaCO2  56 mmHg  33-45 mmHg 
 PaO2  71 mmHg  75-105 mmHg 
 Bicarbonate  25 mmol/L  22-28 mmol/L 
   
The patient’s condition improves with administration of edrophonium chloride. Which of the following best describes the cause of this patient’s condition? 

Transcript

Watch video only

Myasthenia gravis comes from the Greek word ‘myasthenia’, meaning muscle weakness; and the Latin word ‘gravis’, meaning severe. So, myasthenia gravis is an autoimmune condition that causes serious muscle weakness.

First, let's focus on physiology and how muscles normally work. Whether you’re reaching for a slice of pizza or sinking that perfect shot in basketball, it all starts in the brain. The upper motor neuron of the cerebral cortex fires an action potential down the spinal cord to activate lower motor neurons. Next, lower motor neurons pick up these signals and pass them along their axons toward terminal branches and axon terminals, all the way to skeletal muscle fibers.

This communication site between the lower motor neuron and the skeletal muscle fiber is known as the neuromuscular junction, which consists of three main parts. First, there’s the presynaptic membrane, which is the axon terminal of the lower motor neuron packed with acetylcholine vesicles. Acetylcholine is actually the neurotransmitter that enables muscle contraction. Next, there’s the postsynaptic membrane, which is the membrane of the skeletal muscle fiber, rich in nicotinic acetylcholine receptors.

Finally, this tiny space between two membranes is called the synaptic cleft and contains the enzyme acetylcholine esterase.

Now, the arrival of the action potential at the axon terminal triggers the opening of voltage-gated calcium channels in the presynaptic membrane, allowing calcium ions to rush in. This triggers the acetylcholine vesicles to fuse with the presynaptic membrane and release acetylcholine into the synaptic cleft. Once inside the cleft, acetylcholine moves across to bind nicotinic acetylcholine receptors on the postsynaptic membrane. Eventually, this binding triggers the muscle cell to depolarize, setting off a chain of intracellular events that lead to contraction. Once the contraction is over, acetylcholine is broken down by acetylcholine esterase, allowing the muscle to relax and prepare for the next signal.

In myasthenia gravis, the immune system produces antibodies that disrupt the normal function of nicotinic acetylcholine receptors. Now, there are three types of autoantibodies. First, we have blocking antibodies, which bind and block acetylcholine receptors, so acetylcholine can’t activate them. Next, there are binding antibodies, which bind the receptors and activate the complement system, eventually destroying them. Finally, the third type includes modulating antibodies, which bind the receptors and trigger the muscle cell to pull the entire receptor inside.

As more receptors are blocked, destroyed, or removed from the postsynaptic membrane, it becomes harder for muscles to receive signals, leading to muscle weakness.

But that's not all. Sometimes, the immune system does not directly attack the acetylcholine receptors. Instead, it targets other important proteins that help neuromuscular junctions work properly, like Muscle Specific Kinase and Lipoprotein Related Protein 4. When they are disrupted, the connection between nerves and muscles becomes unstable or weak, making it even harder for signals to reach the muscle and causing further muscle weakness.

Now, several risk factors contribute to myasthenia gravis, including thymic abnormalities and genetics. In thymic hyperplasia, the thymus enlarges and forms reactive B-cell follicles that produce autoantibodies. Next up is thymoma, which is a tumor that arises from the epithelial cells of the thymus. Both conditions can cause the thymus to misguide the immune system into attacking acetylcholine receptors.

Next up are genetic factors. Certain HLA subtypes, which are genes that help control the immune system, can make someone more likely to develop autoimmune conditions like myasthenia gravis. Moreover, myasthenia gravis often shows up alongside other autoimmune diseases, such as thyroiditis, lupus, or rheumatoid arthritis.

Now, moving to clinical manifestations. As the immune system blocks, destroys or removes receptors from the postsynaptic membrane, muscles have a hard time receiving signals. Ultimately this leads to muscle weakness and fatigue, which is more pronounced in the proximal muscles.

Remember when you were a kid and spent the whole day in the backyard shooting basketballs? Imagine that after a few throws your muscles start to feel weak. You’d have to stop and rest before you could keep playing. Well, that’s what it’s like for someone with myasthenia gravis. Their muscles get tired quickly, even with simple things like brushing their teeth or combing their hair.

Key Takeaways

Myasthenia gravis is an autoimmune disease, specifically a type II hypersensitivity disorder, which is characterized by autoantibodies against nicotinic acetylcholine receptors on the surface of muscle cells.

The antibodies block the receptors which means the signal to contract isn't received. Those antibodies also activate the complement pathway which leads to muscle cell destruction.

Symptoms can range from mild to severe and may include drooping eyelids, difficulty speaking or swallowing, and muscle weakness in the arms and legs. Treatment involves immunosuppressive drugs like prednisolone, and acetylcholinesterase inhibitors like neostigmine. The purpose is to reduce the immune system's attack on the muscle and to increase muscle strength.

Sources

  1. "Robbins & Kumar Basic Pathology. Available from: ClinicalKey Student, (11th Edition). " Elsevier Limited (UK) (2022. Page 718-720 )
  2. "Conn's Current Therapy 2025. Available from: ClinicalKey Student" Elsevier Limited (UK) (2024. Page 806-811 )
  3. "Crush Step 1 E-Book. Available from: ClinicalKey Student, (3rd Edition)" Elsevier Limited (UK) (2023. Page 461-471 )